Glenmark Life Sciences standalone net profit declines 5.52% in the March 2022 quarter

Sales rise 10.04% to Rs 514.06 crore

Net profit of Glenmark Life Sciences declined 5.52% to Rs 98.90 crore in the quarter ended March 2022 as against Rs 104.68 crore during the previous quarter ended March 2021. Sales rose 10.04% to Rs 514.06 crore in the quarter ended March 2022 as against Rs 467.16 crore during the previous quarter ended March 2021.

For the full year,net profit rose 19.10% to Rs 418.72 crore in the year ended March 2022 as against Rs 351.58 crore during the previous year ended March 2021. Sales rose 12.63% to Rs 2123.21 crore in the year ended March 2022 as against Rs 1885.17 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales514.06467.16 10 2123.211885.17 13 OPM %27.6736.36 -29.0231.35 - PBDT147.19149.04 -1 602.80504.34 20 PBT137.64140.61 -2 564.92470.95 20 NP98.90104.68 -6 418.72351.58 19

Powered by Capital Market - Live News